4.2 Abstract in Atti di convegno

4.2 Abstract in Atti di convegno: [3017] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 821 a 840 di 3.017

Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center

2007-01-01 Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F

Mcl-1 Fragment Mcl-1128-350 Induces Inhibition of Multiple Myeloma Cell Proliferation and Apoptosis

2009-01-01 Podar, K; Zimmerhacki, A; Zhang, J; Tonon, G; Barila, D; Vallet, S; Sattler, M; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Kc

Salvage therapy in primary central nervous system lymphomas (PCNSL)

1998-01-01 Reni, M; Ferreri, Ajm; Truci, G; Canal, N; Villa, E

Expression of apoptotic markers in activated platelets is mediated in part by cathepsin

1998-01-01 Tonon, G; Luo, X; Chen, W; Shi, Y; Greco, N; Cattaneo, M; Jamieson, Ga

A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

2009-01-01 Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E

In vitro and in vivo activity of the VEGF inhibitor pazopanib

2007-01-01 Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc

Preliminary results of a phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil and gemcitabine) in advanced gallbladder, biliary tract and ampulla of Vater adenocarcinoma

2002-01-01 Passoni, P; Reni, M; Zanello, A; Et, Al.

Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL

2016-01-01 Agathangelidis, A; Ljungstrom, V; Scarfo, L; Fazi, C; Gounari, M; Pandzic, T; Sutton, La; Stamatopoulos, K; Tonon, G; Rosenquist, R; Ghia, P

Salvage therapy with temozolomide in immunocompetent patients with primary brain lymphoma

2001-01-01 Reni, M; Ferreri, Ajm; Candela, M; Abbadessa, A; Villa, E

Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma

2014-01-01 Cottini, F; Hideshima, T; Buhrlage, S; Gray, Ns; Richardson, Pg; Tonon, G; Anderson, Kc

Second line treatment for primary central nervous system lymphomas (PCNSL)

2000-01-01 Reni, M; Ferreri, Ajm.

Exploiting oncogene-induced DNA replicative stress as synthetic lethal approach to target myeloma

2015-01-01 Cottini, F; Hideshima, T; Richardson, P; Anderson, K; Tonon, G

Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial

2004-01-01 Dell'Oro, S; Reni, M; Bonetto, E; Panucci, Mg; Vigano, Mg; Zerbi, A; Balzano, G; Di Carlo, V; Staudacher, C; Villa, E

Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells.

1997-01-01 Greco, Nj; Chen, Wd; Tonon, G

Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer

2006-01-01 Vitali, G; Ronzoni, M; Passoni, P; Staudacher, C; Di Palo, S; Cereda, S; Reni, M; Villa, E

EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES

2013-01-01 Campanella, A; Bertilaccio, S; Santambrogio, P; Marcatti, M; Sitia, R; Tonon, G; Camaschella, C

Optimal radiation therapy (RT) for primary central nervous system lymphomas (PCNSL) in immunocompetent patients: a critical review of the literature

1996-01-01 Reni, M; Ferreri, Ajm; Villa, E

TARGETING ANGIOGENESIS VIA A C-MYC/HIF-1 alpha-DEPENDENT PATHWAY IN MM

2009-01-01 Podar, K; Zhang, J; Tonon, G; Grabher, C; Lababidi, S; Zimmerhackl, A; Raab, Mr; Sonia, S; Zhou, Y; Cartron, Ma; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Ka

XELIRI OR FOLFIRI AS SALVAGE THERAPY IN ADVANCED PANCREATIC CANCER

2010-01-01 Cereda, S; Reni, M; Rognone, A; Ghidini, M; Belli, C; Longoni, S; Fugazza, C; Brioschi, M; Villa, E

The MEK1/2 inhibitor AZD6244 (ARRY-142886) downregulates constitutive and adhesion-induced c-MAF oncogene expression and its downstream targets in human multiple myeloma

2006-01-01 Tai, Yt; Tonon, G; Li, Xf; Rumizen, M; Song, Wh; Morrison, A; Burger, P; Munshi, Nc; Anderson, Kc

Titolo	Data di pubblicazione	Autore(i)
Hypothalamic-pitiuitary fnction in adults exposed to cranial irradiation for nonpituitary primary brain tumours: Preliminary report of one single center	1-gen-2007	Motta, M; Perna, L; Losa, M; Lanzi, R; Madaschi, S; Bolognesi, A; Fiorino, C; Mazza, E; Guerra, C; Reni, M; Calandrino, R; Fazio, F
Mcl-1 Fragment Mcl-1128-350 Induces Inhibition of Multiple Myeloma Cell Proliferation and Apoptosis	1-gen-2009	Podar, K; Zimmerhacki, A; Zhang, J; Tonon, G; Barila, D; Vallet, S; Sattler, M; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Kc
Salvage therapy in primary central nervous system lymphomas (PCNSL)	1-gen-1998	Reni, M; Ferreri, Ajm; Truci, G; Canal, N; Villa, E
Expression of apoptotic markers in activated platelets is mediated in part by cathepsin	1-gen-1998	Tonon, G; Luo, X; Chen, W; Shi, Y; Greco, N; Cattaneo, M; Jamieson, Ga
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel	1-gen-2009	Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E
In vitro and in vivo activity of the VEGF inhibitor pazopanib	1-gen-2007	Podar, K; Tonon, G; Sattler, M; Tai, Yt; Legouill, S; Yasui, H; Ishitsuka, K; Kumar, S; Kumar, R; Pandite, Ln; Hideshima, T; Chauhan, D; Anderson, Kc
Preliminary results of a phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil and gemcitabine) in advanced gallbladder, biliary tract and ampulla of Vater adenocarcinoma	1-gen-2002	Passoni, P; Reni, M; Zanello, A; Et, Al.
Profiling the Genomic Landscape at the Early Stages of CLL: Low Genomic Complexity and Paucity of Driver Mutations in MBL and Indolent CLL	1-gen-2016	Agathangelidis, A; Ljungstrom, V; Scarfo, L; Fazi, C; Gounari, M; Pandzic, T; Sutton, La; Stamatopoulos, K; Tonon, G; Rosenquist, R; Ghia, P
Salvage therapy with temozolomide in immunocompetent patients with primary brain lymphoma	1-gen-2001	Reni, M; Ferreri, Ajm; Candela, M; Abbadessa, A; Villa, E
Serine/Threonine Kinase STK4 Is a Novel Target in Myeloma	1-gen-2014	Cottini, F; Hideshima, T; Buhrlage, S; Gray, Ns; Richardson, Pg; Tonon, G; Anderson, Kc
Second line treatment for primary central nervous system lymphomas (PCNSL)	1-gen-2000	Reni, M; Ferreri, Ajm.
Exploiting oncogene-induced DNA replicative stress as synthetic lethal approach to target myeloma	1-gen-2015	Cottini, F; Hideshima, T; Richardson, P; Anderson, K; Tonon, G
Intensified PEFG regimen in stage III-IV pancreatic adenocarcinoma: A phase I trial	1-gen-2004	Dell'Oro, S; Reni, M; Bonetto, E; Panucci, Mg; Vigano, Mg; Zerbi, A; Balzano, G; Di Carlo, V; Staudacher, C; Villa, E
Identification of alternative forms of a P2X(1) receptor in platelets and megakaryocytic cells.	1-gen-1997	Greco, Nj; Chen, Wd; Tonon, G
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer	1-gen-2006	Vitali, G; Ronzoni, M; Passoni, P; Staudacher, C; Di Palo, S; Cereda, S; Reni, M; Villa, E
EXPLOITING IRON TOXICITY IN MULTIPLE MYELOMA: A STRATEGY TO INCREASE THE EFFICACY OF PROTEASOME INHIBITION THERAPIES	1-gen-2013	Campanella, A; Bertilaccio, S; Santambrogio, P; Marcatti, M; Sitia, R; Tonon, G; Camaschella, C
Optimal radiation therapy (RT) for primary central nervous system lymphomas (PCNSL) in immunocompetent patients: a critical review of the literature	1-gen-1996	Reni, M; Ferreri, Ajm; Villa, E
TARGETING ANGIOGENESIS VIA A C-MYC/HIF-1 alpha-DEPENDENT PATHWAY IN MM	1-gen-2009	Podar, K; Zhang, J; Tonon, G; Grabher, C; Lababidi, S; Zimmerhackl, A; Raab, Mr; Sonia, S; Zhou, Y; Cartron, Ma; Tai, Yt; Hideshima, T; Chauhan, D; Anderson, Ka
XELIRI OR FOLFIRI AS SALVAGE THERAPY IN ADVANCED PANCREATIC CANCER	1-gen-2010	Cereda, S; Reni, M; Rognone, A; Ghidini, M; Belli, C; Longoni, S; Fugazza, C; Brioschi, M; Villa, E
The MEK1/2 inhibitor AZD6244 (ARRY-142886) downregulates constitutive and adhesion-induced c-MAF oncogene expression and its downstream targets in human multiple myeloma	1-gen-2006	Tai, Yt; Tonon, G; Li, Xf; Rumizen, M; Song, Wh; Morrison, A; Burger, P; Munshi, Nc; Anderson, Kc

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 821 a 840 di 3.017

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2961
reserved34
open22